Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy

Oncolytic virotherapy (OVT) is a novel type of immunotherapy that induces anti-tumor responses through selective self-replication within cancer cells and oncolytic virus (OV)-mediated immunostimulation. Notably, talimogene laherparepvec (T-Vec) developed by the Amgen company in 2015, is the first FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ban, Weiyue, Guan, Jianhuan, Huang, Hanwei, He, Zhonggui, Sun, Mengchi, Liu, Funan, Sun, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tsinghua University Press 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852960/
https://www.ncbi.nlm.nih.gov/pubmed/35194488
http://dx.doi.org/10.1007/s12274-021-4031-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852960/
https://www.ncbi.nlm.nih.gov/pubmed/35194488
http://dx.doi.org/10.1007/s12274-021-4031-6

Ejemplares similares